Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-26

Clinical Trial Update: Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II) [Phase 3]

View source ↗

Summary

Phase 3 E4Comfort II trial evaluating estetrol for moderate-to-severe vasomotor symptoms in postmenopausal women has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estetrol (estetrol)

Snippet

Sponsor: Estetra | Conditions: Vasomotor Symptoms, Menopausal Symptoms | Phase 3 | Status: COMPLETED | Results posted: 2025-12-26